The Weekly Litigation News Digest is now live. Subscribe now

Sulodexide For Use In The Treatment Of Pathologies Wherein Metalloproteinases Are Involved - EP2560662

The patent EP2560662 was granted to Alfasigma on Jun 7, 2017. The application was originally filed on Apr 20, 2011 under application number EP11723652A. The patent is currently recorded with a legal status of "Revoked".

EP2560662

ALFASIGMA
Application Number
EP11723652A
Filing Date
Apr 20, 2011
Status
Revoked
Mar 6, 2020
Publication Date
Jun 7, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOTTI & FERRARIMar 7, 2018FERRECCIO -
GENERICS UKMar 7, 2018FRKELLY -

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP1292315
DESCRIPTIONUS3936351
DESCRIPTIONUS4705798
DESCRIPTIONUS5455258
DESCRIPTIONWO9005719
DESCRIPTIONWO9402447
DESCRIPTIONWO9720824
EXAMINATIONEP0950413
EXAMINATIONWO2009121959
OPPOSITIONWO2009121959
OPPOSITIONWO2011051726

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents